According to MoH uptake of the second HPV dose is 31per cent while the uptake of the first dose stands at 61 per cent among girls in Kenya. Mouth, throat, penis and anus cancers ...

Kenya has introduced the single-dose human papillomavirus (HPV) vaccine, replacing the previous two-dose regimen, to increase the chances of protection against the virus and related diseases such ...

The HPV vaccine can prevent cancers, including cervical cancer. It's recommended for girls between the ages nine and 45. Only about three in 10 eligible girls in Kenya received the human ...

HPV is fuelling high cervical cancer rates in sub-Saharan Africa despite the availability of effective vaccines. Yet uptake remains low, driven largely by vaccine hesitancy. In South Africa alone ...

One dose of a human papillomavirus (HPV) vaccine was noninferior to two doses in preventing infection, data from a randomized trial showed. In the ESCUDDO trial, which involved more than 20,000 ...

The global Human Papillomavirus (HPV) Vaccines market, valued at USD 5.5 billion in 2024, is anticipated to grow to USD 9.7 billion by 2030 at a CAGR of 9.9%. This report offers comprehensive ...

The first trial of an AI (Artificial Intelligence)-powered chatbot designed to inform parents about the HPV vaccine has shown that it increases vaccine uptake and engagement with health professionals.

The researchers found that uptake of the first HPV vaccine dose was 80.7% and was lower for those with versus without any mental health condition (adjusted relative risk, 0.89).

For more information on this research see: Accountable Care Organizations and Hpv Vaccine Uptake: a Multilevel Analysis. The American Journal of Managed Care, 2024;30(10).